Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Surfactant replacement therapy.

R G Spragg1

  • 1Department of Medicine, University of California San Diego, USA. rspragg@ucsd.edu

Clinics in Chest Medicine
|October 6, 2000
PubMed
Summary

Surfactant dysfunction worsens acute lung injury (ALI). Exogenous surfactant treatment improves lung function in animal models and shows promise in human clinical trials for ALI, with phase III trials underway.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pathology of the surfactant system of the mature lung: second San Diego conference.

American journal of respiratory and critical care medicine·2001
Same author

ARDS and the search for meaningful subgroups.

Intensive care medicine·2000
Same author

Reperfusion lung injury after unilateral pulmonary artery occlusion.

Respirology (Carlton, Vic.)·2000
Same author

Effect of recombinant SP-C surfactant in a porcine lavage model of acute lung injury.

Journal of applied physiology (Bethesda, Md. : 1985)·2000
Same author

Effect of phosphocholine cytidylyltransferase overexpression on phosphatidylcholine synthesis in alveolar type II cells and related cell lines.

American journal of respiratory cell and molecular biology·1999
Same author

Analyzing the time and value of housestaff inpatient work.

Journal of general internal medicine·1998

Area of Science:

  • Pulmonary Medicine
  • Critical Care Medicine
  • Biochemistry

Background:

  • Acute lung injury (ALI) involves surfactant system dysfunction.
  • Alveolar type II cell injury and plasma protein inhibition impair surfactant function in ALI.
  • Surfactant dysfunction contributes significantly to ALI pathophysiology.

Purpose of the Study:

  • To investigate the role of surfactant system dysfunction in ALI.
  • To evaluate the therapeutic potential of exogenous surfactant in ALI.

Main Methods:

  • Review of mechanisms contributing to surfactant dysfunction in ALI.
  • Analysis of preclinical animal models of ALI treated with exogenous surfactant.
  • Summary of clinical trial data for surfactant therapy in ALI.

Main Results:

  • Exogenous surfactant administration markedly improved gas exchange in animal models of ALI.
  • Clinical studies indicate potential benefit from surfactant treatment for ALI.
  • Definitive phase III clinical trials are currently in progress.

Conclusions:

  • Surfactant system dysfunction is a key component of ALI.
  • Exogenous surfactant therapy represents a promising treatment strategy for ALI.
  • Further clinical validation through phase III trials is essential.

Related Experiment Videos